Govt Mulls Norms For QR Code On Cosmetics, Apparel Brands To Curb Counterfeits

New Delhi: India is looking to lay down norms to counter the menace of counterfeit products mimicking the names and labels of brands of garments, apparel and cosmetics. The representatives from garments, apparel and cosmetics’ industries stated that they’re ready to share available data on counterfeit products to aid better policymaking by the government, sources told CNBC-TV18.

These entities met with Consumer Affairs Secretary Rohit Kumar Singh and discussed checking the sale of fake or counterfeit brands of apparel and cosmetics. The government is mulling guidelines to install QR codes on branded apparel and cosmetics to ease identification by users, as per sources. The proposed guidelines also aim to cover cosmetics sold via social media posts or reels.
Sources indicated that the government is mulling guidelines to install QR codes on branded apparel and cosmetics to ease identification by users. The proposed guidelines also aim to cover cosmetics sold via social media posts or reels.
A joint report issued by Credit Rating Information Services of India Limited (CRISIL) and the Authentication Solution Providers Association (ASPA) in January 2024 pointed out that 25% to 30% of all products sold in India were spurious. The report termed counterfeiting the most prevalent in the apparel and fast-moving consumer goods (FMCG) sectors.
The report claims 31% counterfeit products among apparel, followed by 28% in the FMCG segment, 25% in automotives, 20% in pharmaceuticals, 17% in consumer durables and 16% in agrochemicals.
The report covered 12 Indian cities: Jalandhar, Delhi, Agra, Jaipur, Patna, Indore, Ahmedabad, Kolkata, Mumbai, Hyderabad, Bangalore and Chennai. It also contended that 31% of consumers willingly bought spurious products, while 27% of consumers were unaware of having bought counterfeit products.

Related Posts

  • Pharma
  • March 20, 2025
  • 48 views
Patanjali’s study on Renogrit, that fights cancer drug-induced kidney damage, among 2024’s most notable research papers

A research paper published on Patanjali’s Renogrit, a formulation that is effective against cancer drug cisplatin’s damaging effect on kidneys, has been featured among the most notable research studies of 2024.…

  • Pharma
  • March 19, 2025
  • 123 views
Strides Pharma approves demerger from Arco Labs

Strides Pharma is set to demerge from Arco Labs, a global capability centre, the company said in its exchange filing on Wednesday. Board of Directors of Strides Pharma Science Limited (Strides) and Arco…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Patanjali’s study on Renogrit, that fights cancer drug-induced kidney damage, among 2024’s most notable research papers

Patanjali’s study on Renogrit, that fights cancer drug-induced kidney damage, among 2024’s most notable research papers

Strides Pharma approves demerger from Arco Labs

Strides Pharma approves demerger from Arco Labs

Milestone Pharma Expands Sale Agreement, Increases Offering

Milestone Pharma Expands Sale Agreement, Increases Offering

Novo Nordisk regains membership in UK pharma body

Novo Nordisk regains membership in UK pharma body

USV Joins Empagliflozin generic contest, launches its brand Xenia

USV Joins Empagliflozin generic contest, launches its brand Xenia

SMS Hospital revamps blood safety protocols after fatal transfusion error

SMS Hospital revamps blood safety protocols after fatal transfusion error